HDAC3 and fatty liver disease: HDAC3 is recruited to the promoter of PPARγ2 by retinoic acid receptor-related orphan receptor-α and represses PPARγ2 expression by deacetylation, thereby downregulating the expression of its target fatty acid uptake genes and preventing hepatic steatosis [16].